Related Experiment Video
Updated: Aug 21, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Platelet function, coagulopathy, and impaired fibrinolysis in diabetes
Burton E Sobel1, David J Schneider
1Department of Medicine, University of Vermont, Colchester Research Facility, 208 South Park Drive, Colchester, VT 05446, USA. burt.sobel@vtmednet.org
Insights
Diabetes and metabolic syndrome create a hyper-coagulable state, increasing risks for atherosclerosis and heart disease due to blood clotting issues. Understanding these mechanisms is key to managing cardiovascular complications in patients.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Hematology
Background:
- Diabetes mellitus and metabolic syndrome are characterized by a hyper-coagulable state.
- Key features include increased platelet reactivity, enhanced coagulation system activity, and impaired fibrinolysis.
- These hemostatic abnormalities are well-characterized and contribute significantly to disease pathology.
Purpose of the Study:
- To summarize the pro-thrombotic mechanisms associated with diabetes and metabolic syndrome.
- To highlight the contribution of these mechanisms to accelerated atherosclerosis and cardiovascular disease.
- To underscore the clinical significance of understanding these hemostatic derangements.
Main Methods:
- Review of existing literature on coagulation and fibrinolysis in diabetes and metabolic syndrome.
- Analysis of characteristic features of hyper-coagulability in these conditions.
- Synthesis of data linking hemostatic changes to clinical outcomes.
Main Results:
- Diabetes and metabolic syndrome demonstrably increase blood coagulability.
- Elevated platelet activity, augmented coagulation factors, and reduced fibrinolytic capacity are consistently observed.
- These alterations are understood to a significant extent.
Conclusions:
- The pro-thrombotic state in diabetes and metabolic syndrome is a major contributor to premature cardiovascular disease.
- Understanding these mechanisms is crucial for mitigating the profound cardiovascular toll associated with these metabolic disorders.
- Targeting hemostatic pathways may offer therapeutic strategies for affected patients.
Abstract:
Diabetes and the metabolic syndrome, including insulin resistance, that underlies it are hyper-coagulable states. Increased platelet reactivity,augmented activity of the coagulation system,and impaired fibrinolysis are characteristic and understood to a remarkable extent. In aggregate,these derangements contribute to accelerated atherosclerosis, premature coronary artery dis-ease, and a profound toll from both.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Diabetic Foot Ulcer
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

